Investment ThemesDetailed Quotes
Mpox (monkeypox)
Watchlist
- 1239.566
- -11.473-0.92%
Close Feb 14 16:00 ET
1254.232High1239.426Low
1251.586Open1251.039Pre Close21.24MVolume7RiseLossP/E (Static)1.46BTurnover--Flatline0.22%Turnover Ratio638.29BMarket Cap7Fall636.28BFloat Cap
Constituent Stocks: 14Top Rising: TNXP+4.55%
Revolutionary Brain Cancer Drug Gets Fast-Track to FDA Approval: Chimerix's Hope for Untreatable Glioma
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
Chimerix (NASDAQ: CMRX) announced FDA acceptance of its New Drug Application (NDA) for dordaviprone, targeting recurrent H3 K27M-mutant diffuse glioma treatment. The application received Priority Review status with a PDUFA target action date of August 18, 2025.
The FDA has not planned an advisory committee meeting for th...
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
65k returned
I've got my eyes on this and will likely be taking a position on Tuesday. Keep it on watch or consider a swing position.
No comment yet